Department of Cancer Genetics
Department head: Therese Sørlie
Department deputy head (adm): Gry Aarum Geitvik
Department secretary: Mona Hagen
Vision: Towards personalized therapy for cancer; integrated molecular and epidemiological studies to reduce risk, achieve early diagnosis, improve prognosis, and tailor the treatment for breast, lung, pancreatic and ovarian cancer.
Our aim is to improve risk estimation, achieve earlier diagnosis and improve prediction of treatment responses and other clinical outcomes for patients with early and advanced stages of both solid tumors and hematologic malignancies. Our research is translational in nature and include functional studies, molecular classification, data integration and pan-cancer analyses. We work towards facilitating the implementation of discoveries into clinical use. A common theme across groups is to achieve a deeper molecular understanding of inter- and intra-tumor heterogeneity and tumor evolution using patient cohorts and mouse models.